Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immune (Idiopathic) Thrombocytopenic Purpura”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT06199089
What this trial is testing

A Randomized, Double-blind, Placebo-controlled, and Multi-center Clinical Study of CM313 in the Treatment of Immune Thrombocytopenia

Who this might be right for
Immune ThrombocytopeniaTreatment
Institute of Hematology & Blood Diseases Hospital, China 45
Large-scale testing (Phase 3)Study completedNCT00699140
What this trial is testing

Clinical Trial in Patients Diagnosed With Immune Thrombocytopenic Purpura

Who this might be right for
Immune (Idiopathic) Thrombocytopenic Purpura
Instituto Grifols, S.A. 18
Not applicableUnknownNCT04913597
What this trial is testing

Switching Avatrombopag and Rh-TPO in ITP

Who this might be right for
Corticosteroid-resistant or Relapsed ITP
Peking University People's Hospital 100
Large-scale testing (Phase 3)Study completedNCT02076399
What this trial is testing

A Efficacy and Safety Study of R935788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP)

Who this might be right for
Immune Thrombocytopenic Purpura
Rigel Pharmaceuticals 76
Not applicableUnknownNCT00006055
What this trial is testing

Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases

Who this might be right for
Purpura, Schoenlein-HenochGraft Versus Host DiseaseAnemia, Hemolytic, Autoimmune+11 more
Fairview University Medical Center 10
Large-scale testing (Phase 3)Study completedNCT01349790
What this trial is testing

Efficacy and Safety of Immunoglobulin Intravenous (Human) 10% (NewGam) in Primary Immune Thrombocytopenia

Who this might be right for
Primary Thrombocytopenia
Octapharma 40
Large-scale testing (Phase 3)WithdrawnNCT01882127
What this trial is testing

All-Trans Retinoic Acid (ATRA) Combining Dexamethasone Versus High-dose Dexamethasone for Initial Treatment of Primary Immune Thrombocytopenia (ITP)

Who this might be right for
PurpuraIdiopathic Thrombocytopenic Purpura
Shandong University
Not applicableStudy completedNCT03576742
What this trial is testing

Severe Immune Cytopenia Registry Www.Sic-reg.Org

Who this might be right for
Immune ThrombocytopeniaAutoimmune Hemolytic AnemiaEvans Syndrome+1 more
Medical University of Graz 80
Large-scale testing (Phase 3)Looking for participantsNCT05338190
What this trial is testing

Efficacy and Safety of Subcutaneous Belimumab or Placebo in Addition of Rituximab in Persistent or Chronic Immune Thrombocytopenia

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
Assistance Publique - Hôpitaux de Paris 132
Testing effectiveness (Phase 2)Looking for participantsNCT07175493
What this trial is testing

CM336 in Patients With Relapsed or Refractory Autoimmune Cytopenia

Who this might be right for
Autoimmune CytopeniaImmune Thrombocytopenia (ITP)Autoimmune Hemolytic Anemia+1 more
Keymed Biosciences Co.Ltd 158
Not applicableNot Yet RecruitingNCT07014904
What this trial is testing

"Cytotoxic T Lymphocyte-Associated Antigen-4 (CTLA-4) Gene Single-nucleotide Polymorphism in Primary Immune Thrombocytopenic Purpura in Children"

Who this might be right for
ITP - Immune Thrombocytopenia
Sohag University 80
Large-scale testing (Phase 3)Not Yet RecruitingNCT07455006
What this trial is testing

Safety and Efficacy Study of QL0911 to Treat Immune Thrombocytopenia (ITP) in Pediatric Patients

Who this might be right for
Thrombocytopenia, Immune
Qilu Pharmaceutical Co., Ltd. 60
Testing effectiveness (Phase 2)Study completedNCT00625443
What this trial is testing

Phase 2, Parallel Group, Rollover Study of AKR-501 in Patients With ChronicITP Who Completed 28 Days of Study Treatment in Protocol 501-CL-003

Who this might be right for
Idiopathic Thrombocytopenic Purpura
Eisai Inc. 53
Testing effectiveness (Phase 2)Looking for participantsNCT06838962
What this trial is testing

Anti-CD38 Antibody Treating Children With Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Immune ThrombocytopeniaTreatment
Institute of Hematology & Blood Diseases Hospital, China 30
Large-scale testing (Phase 3)Study completedNCT02279173
What this trial is testing

Long-term Study of Romiplostim in Thrombocytopenic Pediatric Patients With Immune Thrombocytopenia (ITP)

Who this might be right for
Immune Thrombocytopenia
Amgen 203
Testing effectiveness (Phase 2)Study completedNCT00515203
What this trial is testing

Safety and Efficacy Study of Romiplostim (AMG 531) to Treat ITP in Pediatric Subjects

Who this might be right for
Idiopathic Thrombocytopenic PurpuraThrombocytopenia in Pediatric Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
Amgen 22
Early research (Phase 1)Study completedNCT03275454
What this trial is testing

Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple- Dose BIVV009 in Participants With Chronic Immune Thrombocytopenia (ITP)

Who this might be right for
Purpura, Thrombocytopenic, Idiopathic
Bioverativ, a Sanofi company 12
Early research (Phase 1)WithdrawnNCT06291415
What this trial is testing

The Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HMPL-523 in Adult Subjects With Immune Thrombocytopenia (ITP)

Who this might be right for
Immune ThrombocytopeniaBlood Platelet DisorderHematologic Diseases+14 more
Hutchmed
Early research (Phase 1)UnknownNCT02403440
What this trial is testing

Hetrombopag Olamine in Chronic Idiopathic Thrombocytopenic Purpura (ITP) Patients

Who this might be right for
Purpura, Thrombocytopenic, Idiopathic
Jiangsu HengRui Medicine Co., Ltd. 24
Large-scale testing (Phase 3)UnknownNCT02627417
What this trial is testing

Efficacy and Safety of DAPSone as a Second-line Option in Adult Immune Thrombocytopenia

Who this might be right for
Adult Immune Thrombocytopenia (ITP)Dapsone
Assistance Publique - Hôpitaux de Paris 216
Next Page